Screener
West Pharmaceutical Services WST Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| (in millions, except per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $252.7 | $253.7 |
| Accrued salaries, wages and benefits | 97.1 | 135.9 |
| Income taxes payable | 64.7 | 28.1 |
| Operating lease liabilities | 20.9 | 22.7 |
| Accrued commissions, rebates and royalties | 34.0 | 39.2 |
| Other current liabilities | 171.1 | 175.3 |
| Total current liabilities | 640.5 | 654.9 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's income taxes payable?
- West Pharmaceutical Services (WST) reported income taxes payable of $64.7M in Q2 2026.
- How has West Pharmaceutical Services's income taxes payable changed year-over-year?
- West Pharmaceutical Services's income taxes payable increased by 127.0% year-over-year, from $28.5M to $64.7M.
- What is the long-term trend for West Pharmaceutical Services's income taxes payable?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's income taxes payable has grown at a 1.6% compound annual growth rate (CAGR), from $26M to $28.1M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about West Pharmaceutical Services's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude